An immunohistochemical analysis of over-expression of p53 and c-erbB-2 prot
eins was performed on 27 biopsies of laryngeal carcinoma. The aim of this s
tudy was to investigate whether there is a correlation between over-express
ion of these proteins and the clinicopathological features of the tumor and
to reveal any possible prognostic value. Paraffin sections of laryngeal ca
rcinoma were studied using immunohistochemical staining with mouse and rabb
it monoclonal antibodies, respectively, for p53 and c-erbB-2 proteins. The
positive controls were paraffin-embedded specimens from ten breast carcinom
as previously shown to express these proteins. Ten benign laryngeal nodules
were immunohistochernically stained as negative controls. Samples from 74%
of 27 patients with laryngeal carcinomas demonstrated positive nuclear and
cytoplasmic (or membranous) staining for p53 protein and 48% were positive
for c-erbB-2 protein. In the present study, while there was a slight diffe
rence in the frequency of p53 over-expression among stage I-II and stage II
I-IV tumors, there was no difference in the frequency of p53 over-expressio
n among primary and recurrent tumors. There was no statistically significan
t correlation between over-expression of the p53 and c-erbB-2 proteins and
the age of the patients, tumor site, tumor grade, clinical stage, histopath
ological grading of the tumor, alcohol consumption, and clinical outcome. T
here was a statistically significant correlation between immunostaining of
p53 and c-erbB-2 proteins (P = 0.037). While it was found that over-express
ion of p53 was significantly associated with the presence of lymph node met
astasis (P = 0.006), there was no association between the expression of c-e
rbB-2 and lymph node status. The data demonstrated increased expression of
p53 and c-erbB-2 proteins, presumed to be mutant, in laryngeal carcinomas.
Hence, we conclude that p53 and c-erbB-2 over-expression as detected by imm
unohistochemical staining in larynx carcinomas is not predictive of poor su
rvival or disease-free survival.